MeFirst: A Tailored Intervention to HPV Vaccine Decision Making
| Status: | Completed |
|---|---|
| Conditions: | Infectious Disease |
| Therapuetic Areas: | Immunology / Infectious Diseases |
| Healthy: | No |
| Age Range: | 18 - 26 |
| Updated: | 4/21/2016 |
| Start Date: | January 2013 |
| End Date: | April 2014 |
This study will test whether a tailored, online educational intervention increases HPV
vaccine uptake and intent among female college students.
vaccine uptake and intent among female college students.
MeFirst is the first web-based, online, educational tool designed to promote Human
Papillomavirus (HPV) vaccine awareness and understanding in an effort to improve HPV vaccine
intent and uptake among female university students. HPV is the most common sexually
transmitted infection and causes genital warts and cancer. The HPV vaccine has been
recommended for girls ages 11-26 since 2006, yet vaccination rates remain low. Tailored
online interventions may be more effective tools to promote behavior change among college
students than traditional static interventions. The proposed study is a randomized
controlled trial testing the efficacy of the MeFirst tool vs. standard static educational
material on increasing HPV vaccination intent and uptake among female university students
aged 18-26.
Papillomavirus (HPV) vaccine awareness and understanding in an effort to improve HPV vaccine
intent and uptake among female university students. HPV is the most common sexually
transmitted infection and causes genital warts and cancer. The HPV vaccine has been
recommended for girls ages 11-26 since 2006, yet vaccination rates remain low. Tailored
online interventions may be more effective tools to promote behavior change among college
students than traditional static interventions. The proposed study is a randomized
controlled trial testing the efficacy of the MeFirst tool vs. standard static educational
material on increasing HPV vaccination intent and uptake among female university students
aged 18-26.
Inclusion Criteria:
- enrolled at the University of Michigan
Exclusion Criteria:
- receipt of any doses of HPV vaccine
We found this trial at
1
site
Click here to add this to my saved trials
